COMMUNIQUÉS West-GlobeNewswire

VIVUS Reports Second Quarter 2018 Financial Results

07/08/2018 - 22:05

Company to host conference call today at 4:30pm ET CAMPBELL, Calif., Aug. 07, 2018 (GLOBE NEWSWIRE) -- VIVUS, Inc. (NASDAQ: VVUS) (the "Company"), a specialty pharmaceutical company committed to the development and [...]

Bellicum Pharmaceuticals Reports Second Quarter 2018 Financial Results

07/08/2018 - 22:05

Management to host conference call and webcast today at 5 p.m. Eastern HOUSTON, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular [...]

Cutera Reports Second Quarter 2018 Financial Results

07/08/2018 - 22:05

Second Quarter Revenue of $42.6 Million, an Increase of 17% Year-over-Year Rest of World System Revenue Grew 26% in the Second Quarter BRISBANE, Calif., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Cutera, Inc. (NASDAQ: CUTR ) (“ [...]

OPKO Health Reports Second Quarter 2018 Financial Results

07/08/2018 - 22:05

Conference Call begins today at 4:30 p.m. Eastern Time MIAMI, Aug. 07, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK) reports financial results and business highlights for the three months ended June 30, 2018. [...]

HTG Molecular Diagnostics Reports Second Quarter 2018 Results

07/08/2018 - 22:05

Revenue increased 179% and 190%, respectively, compared to the three and six-month periods in the prior year Call scheduled for today, August 7, at 4:30 pm ET TUCSON, Ariz., Aug. 07, 2018 (GLOBE NEWSWIRE) -- HTG [...]

Tabula Rasa HealthCare Announces Second Quarter 2018 Operating Results

07/08/2018 - 22:05

Second Quarter 2018 Revenue of $48.6 million, growth of 65%; 2018 Revenue Guidance Increased MOORESTOWN, N.J., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare [...]

FibroGen Reports Second Quarter 2018 Financial Results

07/08/2018 - 22:02

Roxadustat U.S. Phase 3 Topline Clinical Data Readout on Track for Fourth Quarter of 2018 Feedback from FDA on Pamrevlumab Pivotal Programs in IPF and in Locally Advanced Unresectable Pancreatic Cancer Conference Call [...]

Allena Pharmaceuticals to Present at 2018 Wedbush PacGrow Healthcare Conference

07/08/2018 - 22:01

NEWTON, Mass., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ:ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics [...]

Vital Therapies Announces Second Quarter 2018 Financial Results

07/08/2018 - 22:01

- On Track for Release of VTL-308 Topline Results in Second Half of September 2018 SAN DIEGO, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq: VTL), a biotherapeutic company developing ELAD®, a cell- [...]

Nuvectra™ Reports Second Quarter 2018 Financial Results

07/08/2018 - 22:01

Reports Record Algovita® Sales of $11.5 million, Up 110% YoY PLANO, Texas, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today financial [...]

Xenon Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update

07/08/2018 - 22:01

Novel Epilepsy Product Candidates – XEN1101 and XEN901 – Continue to Advance in the Clinic New XEN1101 Phase 1b TMS Pharmacodynamic Data to be Presented at upcoming European Congress on Epileptology BURNABY, British [...]

Flexion Therapeutics Reports Second-Quarter 2018 Financial Results and Recent Business Highlights

07/08/2018 - 22:01

Company reported net ZILRETTA ® ( triamcinolone acetonide extended-release injectable suspension) sales of $3.8 million in Q2 representing 73% growth over Q1 Strong progress on the ZILRETTA commercial launch: 60% of [...]

Sientra Reports Second Quarter 2018 Financial Results

07/08/2018 - 22:01

Achieves Record Net Sales of $17.6 Million Appoints Patrick F. Williams to General Manager of miraDry Business Segment Appoints Aesthetics Veteran Paul Little as Chief Financial Officer SANTA BARBARA, Calif., Aug. 07, [...]

MyoKardia to Present at the 2018 Wedbush Pacgrow Healthcare Conference

07/08/2018 - 22:01

SOUTH SAN FRANCISCO, Calif., Aug. 07, 2018 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq:MYOK), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable [...]

MacroGenics Provides Update on Corporate Progress and 2nd Quarter 2018 Financial Results

07/08/2018 - 22:01

ROCKVILLE, Md., Aug. 07, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]

GW Pharmaceuticals plc Reports Fiscal Third Quarter 2018 Financial Results and Operational Progress

07/08/2018 - 22:01

- Epidiolex ® (cannabidiol) oral solution approved by FDA and on track to be launched in Fall - - Conference call today at 4:30 p.m. ET - LONDON and CARLSBAD, Calif., Aug. 07, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals [...]

CytomX to Present at the 2018 Wedbush PacGrow Healthcare Conference

07/08/2018 - 22:01

SOUTH SAN FRANCISCO, Calif., Aug. 07, 2018 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody [...]

Verrica Reports Second Quarter 2018 Financial Results

07/08/2018 - 22:01

WEST CHESTER, Pa., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a pharmaceutical company focused on identifying, developing and commercializing innovative pharmaceutical [...]

Genesis Healthcare Reports Strong Second Quarter 2018 Results

07/08/2018 - 22:01

KENNETT SQUARE, Pa., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Genesis Healthcare, Inc. (Genesis, or the Company) (NYSE:GEN), one of the largest post-acute care providers in the United States, today announced operating results [...]